Swarajya Logo
  • States
  • Politics
  • Economy
  • Business
  • Culture
  • Infra
  • Defence
  • World
  • Books
  • Ideas
  • Science
  • Technology
  • Heritage
  • Archives
  • News Brief
  • Our Views
  • Magazine
  • Headlines
  • Store

antibodies

Two Antibodies Identified In Israel May Fight All Known COVID Strains: Study

PTI
2y Science
image

Covaxin A "Highly Efficacious" COVID-19 Vaccine, Effectively Neutralises Alpha And Delta Variants: US NIH

Swarajya Staff
4y News Brief
image

Delhi: 79 Of 257 Recovered Covid-19 Patients Whose Blood Was Taken During August Sero Survey Had No Antibodies

Swarajya Staff
4y Insta
image

Convalescent Plasma For Covid-19 — Century-Old Treatment Still Lacks Gold Standard Approval

Karan Kamble
4y Science
image

Pune Serosurvey: Does High Prevalence Say Anything About Herd Immunity?

Karan Kamble
4y Science
image

Over 50 Per Cent People In Maharashtra's Pune Have Developed Antibodies For Covid-19, Finds City's First Sero-Survey

IANS
4y Insta
image

US Pharma Giant Eli Lilly Initiates Phase 3 Trial of Its Experimental Antibody Drug LY-CoV555 for Prevention of COVID-19

Swarajya Staff
4y Insta
image

Sero-Prevalence Surveys: A Lot To Cheer Yet Enough Evidence To Caution Indian Cities

Kiran Limaye
4y Ideas
image

Coronavirus: Delhi Govt To Conduct Serological Survey In National Capital Every Month

IANS
4y Insta
image

Over 23 Per Cent Delhiites Have Developed Antibodies For Coronavirus, Reveals Health Ministry's Sero-Prevalence Study

IANS
4y News Brief
image

Scientists Isolate Pair Of Neutralising Antibodies That Could Potentially Block Coronavirus From Entering Host Cells

IANS
5y Insta
image

Get Swarajya in your inbox.


About Swarajya

Shaping the modern Indian's worldview, speaking on behalf of those invested in the cultural and economic prosperity of India. Published since 1956.


Swarajya is a publication by Kovai Media Private Limited.

editor@swarajyamag.com

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Useful Links

  • About Us
  • Subscriptions Support
  • Editorial Philosophy
  • Press Kit
  • Privacy Policy
  • Terms of Use
  • Code of Conduct
  • Plagiarism Policy
  • Refund & Cancellation Policy

Participate

  • Contact Us
  • Write for us
  • Style Guide
  • Jobs

Stay Connected

  • Artboard 2 Copy 6Created with Sketch.
    Artboard 2 Copy 10Created with Sketch.
    Artboard 2 Copy 7Created with Sketch.
    Artboard 2 Copy 9Created with Sketch.
  • Andriod Logo
  • IOS Logo